June 30, 2022
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform
Read More
May 19, 2022
Inceptor Bio Announces $37 Million Series A Financing
Read More
December 16, 2021
Inceptor Bio Enters into In-licensing Agreement For CAR-M Platform
Read More
October 27, 2021
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio
Read More
July 22, 2021
The Past, Present, and Future of Gene Editing
Watch
July 7, 2021
Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers
Read More
June 23, 2021
Beyond CAR-T: Other Engineered Immune Cells
Watch
June 14, 2021
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Read More
October 19-21, 2021
2021 BIO Investor Forum Digital
Book a Meeting
January 10-13, 2022
JP Morgan 40th Annual Healthcare Conference
Book a Meeting